Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity

WM Wolf, RA Wattick, ON Kinkade… - International journal of …, 2018 - mdpi.com
Polycystic ovarian syndrome (PCOS) is thought to be the most common endocrine disorder
found in women. Common symptoms include irregular menstrual cycle, polycystic ovaries …

Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression

M Amiri, F Ramezani Tehrani… - Reproductive Biology …, 2020 - Springer
Background A limited number of publications have assessed the prevalence of hypertension
(HTN) in polycystic ovary syndrome (PCOS) patients with inconclusive results. Since in …

Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study

TR Berni, CL Morgan, DA Rees - The Journal of Clinical …, 2021 - academic.oup.com
Context The effects of polycystic ovary syndrome (PCOS) on cardiovascular morbidity and
mortality are unclear. Objective This work aims to establish the relative risk of myocardial …

[HTML][HTML] Racial and ethnic disparities in polycystic ovary syndrome

K VanHise, ET Wang, K Norris, R Azziz, MD Pisarska… - Fertility and …, 2023 - Elsevier
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that impacts women
worldwide. There are several racial and ethnic differences in PCOS phenotypes and in …

Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review

SN Sendur, BO Yildiz - Reproductive biomedicine online, 2021 - Elsevier
This systematic review aimed to assess variations in the clinical presentation and treatment
outcomes of patients with polycystic ovary syndrome (PCOS) belonging to different …

Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome

M Wang, D Zhao, L Xu, W Guo, L Nie, Y Lei, Y Long… - Metabolism, 2019 - Elsevier
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a critical role in the
cholesterol metabolism by negatively regulating the low-density lipoprotein receptor (LDLR) …

Cardiometabolic risk in polycystic ovary syndrome: current guidelines

LG Cooney, A Dokras - Endocrinology and Metabolism Clinics, 2021 - endo.theclinics.com
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 6% to 10% of
women 1, 2 and is associated with metabolic, reproductive, and psychological implications …

Hypertension risk in young women with polycystic ovary syndrome: a nationwide population-based cohort study

CH Wu, LT Chiu, YJ Chang, CI Lee, MS Lee… - Frontiers in …, 2020 - frontiersin.org
Objective: A number of publications have assessed the prevalence of hypertension in
polycystic ovary syndrome (PCOS) patients with inconclusive results. Since in general …

Self-reported polycystic ovary syndrome is associated with hypertension: a northern Finland birth cohort 1966 study

MME Ollila, K Kaikkonen, MR Järvelin… - The Journal of …, 2019 - academic.oup.com
Context Polycystic ovary syndrome (PCOS) is associated with many traditional
cardiovascular disease risk factors, but it is unclear whether PCOS is an independent risk …

Cardiometabolic features of polycystic ovary syndrome: role of androgens

LL Yanes Cardozo, DG Romero… - Physiology, 2017 - journals.physiology.org
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder that affects
reproductive-age women. Hyperandrogenemia is present in a significant fraction (~ 80%) of …